BNIP3L and Alzheimer disease: The levels of BNIP3L in serum also differed between study subgroups (F [2] = 3.96, p = 0.020, η2 = 0.03) with significantly higher BNIP3L in AD dementia individuals (2.9 ± 2.1 ng/mL) than in MCI-AD (2.1 ± 1.2 ng/mL) (p = 0.015) (Figure 1C).